ADPT
Adaptive Biotechnologies Corp
NASDAQ: ADPT · HEALTHCARE · DIAGNOSTICS & RESEARCH
$28.37
+2.57% today
Updated 2026-10-28
Market cap
$3.83B
P/E ratio
—
P/S ratio
12.44x
EPS (TTM)
$-0.41
Dividend yield
—
52W range
$12 – $31
Volume
2.1M
Adaptive Biotechnologies Corp (ADPT) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$28.37
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$31.48
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.2B | $0.2B | $0.2B | $0.2B | $0.3B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -20.70%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.